PRS44 - INFORMING THE PATHWAY OF COPD TREATMENT (IMPACT STUDY) - SINGLE INHALER TRIPLE THERAPY (FF/UMEC/VI) VERSUS UMEC/VI IN PATIENTS WITH COPD- COST-EFFECTIVENESS ANALYSIS FROM A SOCIETAL PERSPECTIVE IN QUEBEC
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.2438
https://www.valueinhealthjournal.com/article/S1098-3015(18)35740-1/fulltext
Section Title :
Section Order :
1794
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35740-1&doi=10.1016/j.jval.2018.09.2438